Summary
- Current Price
- As of today, CORT price is $69.49, up +1.62% on
- Current Price All-Time High
- CORT price is currently -40.77% below its historical high of $117.33 set on
- Market Cap
- CORT current market cap is $7B, down -9.39% year-over-year
- PE Ratio
- CORT current PE ratio is 198.54
- Revenue
- CORT current annual revenue is $761.41M, up +12.79% year-over-year
- Next Earnings
- The next earnings release for CORT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Corcept Therapeutics Incorporated |
| Ticker | NASDAQ: CORT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | corcept.com |
| Employees | 500 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $69.49 | |
| Price, 1D Change | +1.62% | |
| $7B | ||
| - | ||
| 198.54 | ||
| 1.95 | ||
| $761M | ||
| Revenue, 1Y Change | +12.79% | |
| $0.82 | ||
| EPS, 1Y Change | -33.55% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.82 | ||
| EPS Estimate | N/A | $0.48 |
| EPS Est. Change | N/A | -41.64% |
| $761.41M | ||
| Revenue Estimate | N/A | $988.62M |
| Revenue Est. Change | N/A | +29.84% |
| Current Price | $69.49 | |
| Price Target | - | $75.00 |
| Price Tgt. Change | - | +7.93% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.41 | $1.23 | -12.47% | |
| $0.96 | $0.82 | -14.41% | |
| $0.48 | N/A | -41.64% | |
| $1.63 | N/A | +99.22% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $693.23M | $675.04M | -2.62% | |
| $814.21M | $761.41M | -6.48% | |
| $988.62M | N/A | +29.84% | |
| $1.29B | N/A | +69.45% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $69.49 | |
| $59.48 | ||
| SMA 200 vs Price | -14.40% | |
| $48.03 | ||
| SMA 50 vs Price | -30.89% | |
| 1.95 | ||
| $2.65 | ||
| 84.16 | ||
| 61.67% | ||
| 77.03% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $761.41M | ||
| $0.82 | ||
| $748.43M | ||
| 98.30% | ||
| $44.80M | ||
| 5.88% | ||
| $98.17M | ||
| 12.89% | ||
| $46.69M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 2.89 | ||
| 2.82 | ||
| - | ||
| 6 | ||
| 26.14 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 198.54 | ||
| 9.70 | ||
| 11.69 | ||
| -1,151.33 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $647.81M | ||
| $372.15M | ||
| $838.03M | ||
| $480.40M | ||
| $190.23M | ||
| $166.09M | ||
| $6.11M | ||
| $1.08M | ||
| $40.44M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $663.24M | ||
| $703.63M | ||
| $12.98M | ||
| $0.00 | ||
| $1.89M | ||
| $0.00 | ||
| -$33.19M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $142.00M | ||
| $69.76M | ||
| -$220.37M | ||
| $211.00K | ||
| $141.79M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| UBS | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| Wolfe Research | → | |
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Canaccord Genuity | → |
Analyst sentiment
Institutional ownership
Screeners with CORT
FAQ
What is the ticker symbol for Corcept Therapeutics Incorporated?
The ticker symbol for Corcept Therapeutics Incorporated is NASDAQ:CORT
Does Corcept Therapeutics Incorporated pay dividends?
No, Corcept Therapeutics Incorporated does not pay dividends
What sector is Corcept Therapeutics Incorporated in?
Corcept Therapeutics Incorporated is in the Healthcare sector
What industry is Corcept Therapeutics Incorporated in?
Corcept Therapeutics Incorporated is in the Biotechnology industry
What country is Corcept Therapeutics Incorporated based in?
Corcept Therapeutics Incorporated is headquartered in United States
When did Corcept Therapeutics Incorporated go public?
Corcept Therapeutics Incorporated initial public offering (IPO) was on April 14, 2004
Is Corcept Therapeutics Incorporated in the S&P 500?
No, Corcept Therapeutics Incorporated is not included in the S&P 500 index
Is Corcept Therapeutics Incorporated in the NASDAQ 100?
No, Corcept Therapeutics Incorporated is not included in the NASDAQ 100 index
Is Corcept Therapeutics Incorporated in the Dow Jones?
No, Corcept Therapeutics Incorporated is not included in the Dow Jones index
When was Corcept Therapeutics Incorporated last earnings report?
Corcept Therapeutics Incorporated's most recent earnings report was on April 30, 2026
When does Corcept Therapeutics Incorporated report earnings?
The next expected earnings date for Corcept Therapeutics Incorporated is July 30, 2026
Data Sources & References
- CORT Official Website www.corcept.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.htm
- CORT Profile on Yahoo Finance finance.yahoo.com/quote/CORT
- CORT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cort